{"nct_id":"NCT03238027","title":"A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2017-09-01","start_date_type":"ACTUAL","primary_completion_date":"2020-11-20","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-20","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["SNDX"]}